Your Body's Own Opioids: What We Know and Don't Know About Endogenous Opioid Peptides

This is a narrative review synthesizing published literature on endogenous opioid peptide synthesis, release dynamics, diffusion, degradation, and clinical relevance. The authors reviewed studies spanning molecular biology, neurophysiology, and clinical pharmacology, with a particular focus on recent findings about endomorphin synthesis and naltrexone's mechanism of action in alcohol use disorder.

Despite decades of opioid research, fundamental questions about how the body's own opioid peptides work remain unanswered. This review highlights critical gaps — we still don't fully know how endomorphins are made, how far opioid peptides travel in the brain, or exactly which peptide actions drive specific behaviors. Closing these gaps matters enormously because the opioid system is central to pain, depression, and addiction, and better understanding could lead to more targeted treatments with fewer side effects than current approaches.

The opioid crisis has intensified interest in understanding the body's natural opioid system. If scientists can better understand how endogenous opioid peptides work — which ones drive reward, which ones manage pain, and how they interact — it could lead to more precise treatments for addiction, chronic pain, and depression that harness or modulate the body's own chemistry rather than relying on synthetic opioids with high abuse potential.

As a narrative review, this paper synthesizes existing knowledge rather than generating new data. The authors acknowledge that many fundamental questions remain open, particularly regarding endomorphin synthesis, peptide diffusion distances, and the precise temporal dynamics of release. The naltrexone discussion focuses specifically on alcohol use disorder and may not fully represent its mechanisms in other conditions.